⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14397160 | 0.83 | HCAR3 (0.47) | — | |
| SCHEMBL28856288 | 0.82 | — | — | |
| SCHEMBL17641610 | 0.80 | — | — | |
| SCHEMBL26043543 | 0.77 | KDM5A (0.37) | — | |
| SCHEMBL10663393 | 0.77 | KDM5A (0.37) | — | |
| SCHEMBL10663399 | 0.77 | KDM5A (0.37) | — | |
| SCHEMBL19303858 | 0.75 | ALDH1A1 (0.39) | — | |
| SCHEMBL1662796 | 0.75 | CHEK1 (0.56) | — | |
| SCHEMBL286531 | 0.75 | MAPK1 (0.65) | — | |
| SCHEMBL70577 | 0.74 | HCAR2 (0.59) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011147797-A2 | HYBRID COMPOUND, THE USE THEREOF, AND METHOD FOR THE PRODUCTION THEREOF | Forschungszentrum Jülich GmbH (DE) | 2011-12-01 | — | — | WO | claimed |
| US-12617797-B2 | Substituted pyrazolo [1,5-a]pyrimidines having multimodal activity against pain | ESTEVE PHARMACEUTICALS, S.A. (ES) | 2026-05-05 | — | — | US | disclosed |
| US-20240059690-A1 | PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN | ESTEVE PHARMACEUTICALS, S.A. (ES) | 2024-02-22 | — | — | US | disclosed |
| EP-3747454-B9 | AMYLOID-BETA BINDING PEPTIDES AND THESE PEPTIDES FOR USE IN THE THERAPY AND DIAGNOSIS OF ALZHEIMER'S DEMENTIA | PRIAVOID GMBH (DE) | 2023-10-04 | — | — | EP | disclosed |
| EP-3747454-B1 | AMYLOID-BETA BINDING PEPTIDES AND THESE PEPTIDES FOR USE IN THE THERAPY AND DIAGNOSIS OF ALZHEIMER'S DEMENTIA | PRIAVOID GMBH (DE) | 2023-06-07 | — | — | EP | disclosed |
| EP-4157843-A1 | PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN | ESTEVE PHARMACEUTICALS, S.A. (ES) | 2023-04-05 | — | — | EP | disclosed |
| CN-115698008-A | Pyrazolo [1,5-a ] pyrimidine derivatives having multimodal activity against pain | 埃斯特韦制药股份公司 | 2023-02-03 | — | — | CN | disclosed |
| EP-3346273-B1 | NOVEL D-ENANTIOMERIC PEPTIDES DERIVED FROM D3 AND THEIR USE | PRIAVOID GMBH (DE) | 2023-01-04 | — | — | EP | disclosed |
| EP-3260865-B1 | METHOD FOR THE TREATMENT OF BLOOD, BLOOD PRODUCTS AND ORGANS | PRIAVOID GMBH (DE) | 2022-12-28 | — | — | EP | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-20090239838-A1 | PYRROLOTRIAZINE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2009-09-24 | — | — | US | disclosed |
| US-20090239838-A1 | PYRROLOTRIAZINE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2009-09-24 | — | — | US | disclosed |
| CN-101511835-A | Pyrrolotriazine kinase inhibitors | BRISTOL MYERS SQUIBB CO (US) | 2009-08-19 | — | — | CN | disclosed |
| US-7534792-B2 | e.g. 1-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)pyrrolo[1,2-f][1,2,4]triazin-2-yl)-N-methylpyrrolidine-2-carboxamide; tyrosine kinase inhibitor; anticarcinogenic, antiproliferative agent, neurodegenerative diseases; Alzheimer's disease | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-05-19 | — | — | US | disclosed |
| US-7534792-B2 | e.g. 1-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)pyrrolo[1,2-f][1,2,4]triazin-2-yl)-N-methylpyrrolidine-2-carboxamide; tyrosine kinase inhibitor; anticarcinogenic, antiproliferative agent, neurodegenerative diseases; Alzheimer's disease | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-05-19 | — | — | US | disclosed |
| US-20080009497-A1 | PYRROLOTRIAZINE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2008-01-10 | — | — | US | disclosed |
| US-20080009497-A1 | PYRROLOTRIAZINE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2008-01-10 | — | — | US | disclosed |
| US-20050239808-A1 | Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur | TRANSMIT GESELLSCHAFT FUR TECHNOLOGIETRANSFER MBH (DE) | 2005-10-27 | — | — | US | disclosed |
| EP-1503990-A1 | ACTIVE SUBSTANCES FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF DISEASES IN WHICH ABNORMAL PROTEIN STRUCTURES OCCUR | Transmit Gesellschaft für Technologietransfer mbH (DE) | 2005-02-09 | — | — | EP | disclosed |
| WO-2003095429-A1 | ACTIVE SUBSTANCES FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF DISEASES IN WHICH ABNORMAL PROTEIN STRUCTURES OCCUR | TransMIT Gesellschaft für Technologietransfer mbH (DE) | 2003-11-20 | — | — | WO | disclosed |